Cutler Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$12K Sell
1,000
-2,400
-71% -$201K 0.01% 1201
2023
Q4
$28K Sell
3,400
-2,400
-41% -$160K ﹤0.01% 1765
2023
Q3
$35K Hold
5,800
0.01% 1683
2023
Q2
$37K Buy
5,800
+400
+7% +$29.5K 0.01% 1473
2023
Q1
$29K Sell
5,400
-3,900
-42% -$256K ﹤0.01% 1696
2022
Q4
$96K Sell
9,300
-7,100
-43% -$424K 0.01% 1173
2022
Q3
$16K Sell
16,400
-3,400
-17% -$170K ﹤0.01% 2757
2022
Q2
$106K Buy
19,800
+5,200
+36% +$164K 0.01% 1413
2022
Q1
$79K Buy
14,600
+300
+2% +$9.3K 0.01% 1872
2021
Q4
$54K Sell
14,300
-10,800
-43% -$397K ﹤0.01% 2341
2021
Q3
$89K Buy
25,100
+22,100
+737% +$861K 0.01% 2010
2021
Q2
$30K Sell
3,000
-300
-9% -$18K ﹤0.01% 2932
2021
Q1
$27K Sell
3,300
-1,000
-23% -$70.3K ﹤0.01% 2927
2020
Q4
$71K Sell
4,300
-5,100
-54% -$381K 0.01% 1754
2020
Q3
$79K Buy
9,400
+7,900
+527% +$616K 0.01% 1468
2020
Q2
$30K Sell
1,500
-11,200
-88% -$862K ﹤0.01% 2088
2020
Q1
$40K Sell
12,700
-43,800
-78% -$3.57M ﹤0.01% 1858
2019
Q4
$3.08M Buy
56,500
+46,700
+477% +$1.89M 0.25% 94
2019
Q3
$17K Sell
9,800
-20,500
-68% -$527K ﹤0.01% 2286
2019
Q2
$207K Buy
30,300
+19,900
+191% +$399K 0.02% 696
2019
Q1
$15K Buy
+10,400
New +$96.6K ﹤0.01% 2208

Other funds holding AXSM